|

Systemic Therapy/Standard of Care Clinical Trials

3 actively recruiting trials across 1 location

No change since May 2026

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • The Netherlands Cancer Institute1
  • Ming-Yuan Chen1
  • Memorial Sloan Kettering Cancer Center1

Indications

Other2 trials

Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases
Phase 3
Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy
Phase 3

San Carlos, California1 trial

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Natera, Inc. (Data and Specimen Analysis Only)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.